Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Australia
Division of Paediatrics, Faculty of Medicine, University of Western Australia, Nedlands, Australia.
Eur Respir Rev. 2021 May 11;30(160). doi: 10.1183/16000617.0354-2020. Print 2021 Jun 30.
There is no consensus on how best to measure responses to interventions among children and adults with cystic fibrosis (CF). We have systematically reviewed and summarised the characteristics and measurement properties of tests and tools that have been used to capture outcomes in studies among people with CF, including their reliability, validity and responsiveness. This review is intended to guide researchers when selecting tests or tools for measuring treatment effects in CF trials. A consensus set of these tests and tools could improve consistency in how outcomes are captured and thereby facilitate comparisons and synthesis of evidence across studies.
对于如何最好地衡量囊性纤维化 (CF) 患儿和成人的干预措施的反应,目前尚无共识。我们系统地回顾和总结了用于捕捉 CF 患者研究中结果的测试和工具的特征和测量特性,包括其可靠性、有效性和反应性。这项综述旨在指导研究人员在 CF 试验中选择测试或工具来衡量治疗效果时参考。这些测试和工具的共识集可以提高结果捕捉的一致性,从而促进研究之间的比较和证据综合。